These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20063878)

  • 1. Delivery of NADPH-cytochrome P450 reductase antisense oligos using avidin-biotin approach.
    Pillai VC; Yesudas R; Shaik IH; Thekkumkara TJ; Bickel U; Srivenugopal KS; Mehvar R
    Bioconjug Chem; 2010 Feb; 21(2):203-7. PubMed ID: 20063878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies.
    Purow B; Staveley-O'Carroll K
    J Surg Res; 2005 Jan; 123(1):49-54. PubMed ID: 15652950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
    Kang YS; Pardridge WM
    J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
    Hoya K; Guterman LR; Miskolczi L; Hopkins LN
    Drug Deliv; 2001; 8(4):215-22. PubMed ID: 11757779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioconjugation of biotinylated PAMAM dendrons to avidin.
    Tao L; Geng J; Chen G; Xu Y; Ladmiral V; Mantovani G; Haddleton DM
    Chem Commun (Camb); 2007 Sep; (33):3441-3. PubMed ID: 17700875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Yoshikawa T; Pardridge WM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
    Lengler J; Omann M; Düvier D; Holzmüller H; Gregor W; Salmons B; Günzburg WH; Renner M
    Biochem Pharmacol; 2006 Sep; 72(7):893-901. PubMed ID: 16887103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The avidin-biotin complex (ABC) method and other avidin-biotin binding methods.
    Bratthauer GL
    Methods Mol Biol; 2010; 588():257-70. PubMed ID: 20012837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of immobilized avidin with an aequorin-biotin conjugate: an aequorin-linked assay for biotin.
    Feltus A; Ramanathan S; Daunert S
    Anal Biochem; 1997 Dec; 254(1):62-8. PubMed ID: 9398347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: initial applications in anti-HIV antisense drug delivery to the brain.
    Penichet ML; Kang YS; Pardridge WM; Morrison SL; Shin SU
    J Immunol; 1999 Oct; 163(8):4421-6. PubMed ID: 10510383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
    Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
    Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of biotinylated chitosan for substrate-mediated gene delivery.
    Hu WW; Syu WJ; Chen WY; Ruaan RC; Cheng YC; Chien CC; Li C; Chung CA; Tsao CW
    Bioconjug Chem; 2012 Aug; 23(8):1587-99. PubMed ID: 22768969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotin-triggered release of poly(ethylene glycol)-avidin from biotinylated polyethylenimine enhances in vitro gene expression.
    Xiong MP; Forrest ML; Karls AL; Kwon GS
    Bioconjug Chem; 2007; 18(3):746-53. PubMed ID: 17375897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture.
    Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ
    Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisection of biotinylated soft spherical structures.
    Joshi KB; Verma S
    Biophys Chem; 2009 Mar; 140(1-3):129-32. PubMed ID: 19117661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotinylation reagents for the study of cell surface proteins.
    Elia G
    Proteomics; 2008 Oct; 8(19):4012-24. PubMed ID: 18763706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of dendritic molecular transporter that achieves efficient in vivo delivery of morpholino antisense oligo.
    Li YF; Morcos PA
    Bioconjug Chem; 2008 Jul; 19(7):1464-70. PubMed ID: 18564870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
    Pulkkinen M; Pikkarainen J; Wirth T; Tarvainen T; Haapa-aho V; Korhonen H; Seppälä J; Järvinen K
    Eur J Pharm Biopharm; 2008 Sep; 70(1):66-74. PubMed ID: 18555675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.
    Ko YJ; Devi GR; London CA; Kayas A; Reddy MT; Iversen PL; Bubley GJ; Balk SP
    J Urol; 2004 Sep; 172(3):1140-4. PubMed ID: 15311058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.